WO2026103927 - GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC ERBB
National phase entry is expected:
Publication Number
WO/2026/103927
Publication Date
21.05.2026
International Application No.
PCT/CN2025/135704
International Filing Date
18.11.2025
Title **
[English]
GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC ERBB
[French]
ANIMAL NON HUMAIN GÉNÉTIQUEMENT MODIFIÉ PORTEUR D'UN GÈNE ERBB HUMAIN OU CHIMÉRIQUE
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
ZHANG, Shujin
CHANG, Jiahui
LI, Chong
Priority Data
202411645854.5
18.11.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3553 | |
| EPO | Filing, Examination, Granting | 50203 | |
| Japan | Filing, Examination, Granting | 3725 | |
| South Korea | Filing, Examination, Granting | 5414 | |
| USA | Filing, Examination, Granting | 19740 |
Total:
82,635
Contact Us
Abstract[English]
Genetically modified non-human animals that express a human or chimeric (e.g., humanized)ERBB, and methods of use thereof are disclosed.[French]
La présente invention concerne des animaux non humains génétiquement modifiés exprimant un ERBB humain ou chimérique (par exemple, humanisé), ainsi que des procédés d'utilisation associés.